Haemokinesis is focused on removing the barriers of access to basic healthcare elements worldwide, with a specific emphasis on blood group testing and emergency medicine. The company's vision is to ensure that vital diagnostic technology is accessible to anyone, anywhere. With a focus on biotechnology and healthcare, Haemokinesis represents a promising investment opportunity in the field of medical technology and diagnostics. #EverySecondCounts #Haemokinesis #R&D #Immunohaematology
General Information
Get notified when Haemokinesis moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Haemokinesis
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
Australia Market
Biotechnology
About Haemokinesis
Taxonomy: R&D, Immunohaematology, Point-of-Care Testing, Blood Diagnostics, Emergency Medicine, Medical Technology, Healthcare Innovation
No funding data available for Haemokinesis yet.
Get notified when Haemokinesis raises fundingHaemokinesis Alternatives & Competitors
Accel Diagnostics is a developer and manufacturer of blood diagnostic tests and laboratory analyzers...
Transforming personal healthcare by making lab-quality medical testing quick and accessible
Developing point of care testing solutions that empower patients
FAQ About Haemokinesis
Don't just browse. Track.
Signal Tracker monitors Haemokinesis and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.